|
POLE3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.007600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.256000E-01 |
| Normal-vs-Stage2 |
3.623200E-01 |
| Normal-vs-Stage3 |
4.379600E-01 |
| Normal-vs-Stage4 |
1.542960E-01 |
| Stage1-vs-Stage2 |
8.525400E-01 |
| Stage1-vs-Stage3 |
7.705600E-01 |
| Stage1-vs-Stage4 |
5.656600E-01 |
| Stage2-vs-Stage3 |
7.333200E-01 |
| Stage2-vs-Stage4 |
7.829800E-01 |
| Stage3-vs-Stage4 |
4.817400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.517200E-01 |
| Normal-vs-AfricanAmerican |
7.125000E-01 |
| Normal-vs-Asian |
5.733600E-01 |
| Caucasian-vs-AfricanAmerican |
3.303000E-01 |
| Caucasian-vs-Asian |
9.573200E-01 |
| AfricanAmerican-vs-Asian |
4.589200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.167220E-01 |
| Normal-vs-Female |
3.022000E-01 |
| Male-vs-Female |
3.750600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.637600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.459400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.473400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.879200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.875800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.898000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.790200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.547200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.330800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.977800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.678000E-01 |
| Classical-VS-Follicular |
9.424900E-03 |
| Classical-VS-Other |
2.156000E-01 |
| Classical-VS-Normal |
7.677200E-01 |
| Tall-VS-Follicular |
9.784300E-02 |
| Tall-VS-Other |
2.563200E-01 |
| Tall-VS-Normal |
9.515400E-01 |
| Follicular-VS-Other |
8.484000E-01 |
| Follicular-VS-Normal |
1.877720E-02 |
| Other-VS-Normal |
1.573780E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.605170E-01 |
| Normal-vs-N1 |
2.815500E-02 |
| N0-vs-N1 |
1.639840E-01 |
|
|
